Suchergebnisse - "van Dam, Koos P J"

PubPharm (20)

1

T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination

enthalten in: Journal of neurology, neurosurgery, and psychiatry | 2024

von Verstegen, N. | Hagen, R. | Kreher, C. | +71

2

Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination

enthalten in: Allergy | 2024

von Valk, A. | Keijser, J. | van Dam, K. | +28

3

Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection

enthalten in: Frontiers in immunology | 2024

von Keijzer, S. | Oskam, N. | Ooijevaar-de Heer, P. | +14

4

Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after repeated SARS-CoV-2 mRNA vaccination

enthalten in: bioRxiv.org | 2023

von Valk, A. | Keijser, J. | van Dam, K. | +27

5

Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases : long-term humoral immune responses and effects on disease activity

enthalten in: BMC infectious diseases | 2023

von van Dam, K. | Volkers, A. | Wieske, L. | +55

6

Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity

enthalten in: BMC infectious diseases | 2023

von van Dam, K. | Volkers, A. | Wieske, L. | +54

7

SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis

enthalten in: Journal of neurology, neurosurgery, and psychiatry | 2023

von van Kempen, Z. | Stalman, E. | Steenhuis, M. | +58

8

Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis

enthalten in: Annals of neurology | 2023

von van Kempen, Z. | Hogenboom, L. | Toorop, A. | +16

9

Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations

enthalten in: Journal of autoimmunity | 2023

von van Dam, K. | Wieske, L. | Stalman, E. | +56

10

Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases

enthalten in: Annals of the rheumatic diseases | 2022

von Stalman, E. | Wieske, L. | van Dam, K. | +57